Current Lending Environment for Small Healthcare Businesses
The Current Lending Environment for Lower Middle Market Healthcare Businesses
Healthcare has long been one of the most active sectors in the lower middle market, supported by demographic tailwinds, essential services, and recurring revenue models. However, the lending environment for lower middle market (LMM) healthcare businesses has shifted meaningfully over the past 18–24 months. Capital is still available—but it is more selective, more expensive, and more tightly structured than in recent years.
A Market That Is Tighter—but Still Open
The macro backdrop has reshaped lender behavior. Policy rates that moved from near-zero to over 5% in a short period have materially increased debt service burdens for healthcare operators. For many LMM borrowers, all-in cash interest rates that once fell in the 4–6% range are now closer to 9–12%, depending on leverage and structure.
As a result, traditional banks—particularly regional institutions—have reduced risk exposure in healthcare. Industry surveys show that healthcare lending allocations at many banks are down 10–20% from peak levels, with certain subsectors seeing sharper pullbacks. In response, private credit funds have become an increasingly important source of capital, now accounting for a majority of new LMM leveraged healthcare financings.
That said, private credit is not a direct substitute for bank capital. While it offers flexibility, it comes with higher pricing and tighter economics. The market is open—but only for businesses that can withstand a more conservative underwriting lens.
What Lenders Are Focused on Today
Across both banks and private lenders, underwriting priorities have narrowed.
Cash flow quality is paramount. Lenders are prioritizing businesses with stable, recurring revenue and historical EBITDA margins that can absorb higher interest costs. Many lenders now stress deals assuming 100–200 basis points of additional rate pressure, testing whether free cash flow remains positive.
Reimbursement mix has taken on heightened importance. Medicare and Medicaid exposure is not inherently negative, but lenders are closely scrutinizing payer concentration and rate risk. For example, operators with more than 60–70% Medicaid exposure often face lower leverage or additional covenants unless offset by scale or diversification.
Labor economics remain under pressure. According to industry data, clinical wage rates are still up 15–25% versus pre-2020 levels, and staffing costs continue to compress margins across many subsectors. Lenders now routinely ask for detailed labor metrics, including turnover rates, contract labor usage, and productivity benchmarks.
Regulatory and compliance risk also weighs heavily in underwriting. Lenders are placing increased value on centralized billing, documented compliance programs, and clean audit histories, particularly in highly regulated verticals such as behavioral health, home health, and hospice.
Finally, scale matters more than ever. Multi-site platforms with geographic and payer diversification are generally viewed as lower risk than single-site operators, even when headline margins are similar.
How Deal Terms Have Changed
Deal structures have shifted materially from just a few years ago.
Leverage levels are down. Where senior debt multiples of 4.0–4.5x EBITDA were once common for quality LMM healthcare assets, today many lenders are capping leverage closer to 3.0–3.5x, with total debt rarely exceeding 4.5–5.0x even in sponsor-backed transactions.
Pricing has increased accordingly. Spreads on senior secured debt have widened by 200–300 basis points compared to pre-2022 levels, and upfront fees have become more meaningful to lender economics.
Covenants, while sometimes described as “flexible,” often come with tighter EBITDA definitions and enhanced reporting. Amortization has also returned. It is increasingly common to see annual principal amortization of 5–10%, reflecting lender preference for gradual de-risking rather than reliance on refinancing.
Who Is Still Getting Financed
Despite these constraints, lenders remain active in select healthcare subsectors.
Behavioral health continues to attract capital, particularly for platforms with disciplined payer strategies and commercial reimbursement exposure. Home health and hospice businesses with scale—often defined as $10–15 million or more in EBITDA—remain financeable, especially when backed by experienced management teams.
Physician practice management platforms can still access debt capital when they demonstrate centralized infrastructure, diversified specialties, and limited reliance on aggressive add-backs. More broadly, asset-light healthcare services businesses with modest capex requirements and EBITDA margins north of 15% tend to screen well in today’s market.
Where Capital Is Harder to Access
Conversely, some operators are finding financing materially more difficult.
Single-location providers often struggle to attract lenders, particularly if EBITDA is below $3–5 million. Businesses with customer concentration, narrow payer mixes, or EBITDA heavily reliant on pro forma add-backs face heightened skepticism. Many lenders now haircut add-backs by 25–50% during underwriting, if they accept them at all.
How Operators Can Improve Bankability
Preparation is critical. Clean, timely financial reporting is now table stakes. Operators who present conservative forecasts, clearly explain labor strategies, and proactively address reimbursement risk are far better positioned in lender discussions.
Equally important is storytelling. In a cautious market, lenders want clarity and defensibility—not just growth.
Finding the Right Solution
While finding the right debt structure may be a bit more challenging in this market, Nauset Growth Partners can help you review your current needs and develop a strategy for you. The right capital structure is critically important for growth and managing cash flow for smaller healthcare companies. Contact us to walk through your current situation and build a plant around your capital needs.